Introduction {#s0005}
============

Glutathione S-transferases (GSTs), found in virtually all eukaryotes, are a multigene family of phase-II metabolic enzymes, which catalyze the conjugation of reduced glutathione with a variety of endogenous and exogenous electrophilic compounds, including several potentially toxic carcinogens and chemotherapeutic drugs ([@bb0125]), thereby reducing the reactivity of the compounds by making them water soluble and favouring their elimination from the body. In mammals eight classes of GSTs, i.e. alpha (GSTA), mu (GSTM), theta (GSTT), Pi (GSTP), zeta (GSTZ), sigma (GSTS), kappa (GSTK), and omega (GSTO) have been identified ([@bb0210]), based on sequence homology and substrate specificity. The GSTs have well-established polymorphisms in human populations. The proteins encoded by the different alleles show different abilities to metabolize carcinogens and anticancer agents. It suggests an association between GST polymorphism and the risk for a variety of cancers as well as between said polymorphism and varying responses to cancer treatments. GSTs may also modify susceptibility in certain ethnic groups, showing ethnic dependent polymorphism.

Among all classes of GSTs, *GSTM1*, *GSTT1* and *GSTP1* polymorphisms are extensively studied worldwide. The *GSTM1* and *GSTT1* genes are located on chromosome 1p13.3, and 22q11.2 respectively. Homozygous deletions of *GSTM1* and *GSTT1* genes are common and result in a complete loss of enzyme activity. The frequencies of *GSTM1* null alleles display race and ethnic variations, being highest in Europeans (42--60%) & Asians (41--63%) compared with that of Africans (16--36%) ([@bb0080], [@bb0105], [@bb0125], [@bb0155]). However, the frequency of *GSTT1* null genotypes is somewhat less in Europeans (13.31%) compared with that of Africans (14--57%) and in Asians (35--48%) ([@bb0080], [@bb0125], [@bb0155], [@bb0275]).

The glutathione *S*-transferase P1 (*GSTP1*) gene spanning approximately 2.8 kb is located at 11q13 and contains seven exons ([@bb0085], [@bb0150]). Two polymorphic sites in the coding DNA sequence of the *GSTP1* gene have been identified, which are characterized by an A→G transition at nucleotide 313, translating an isoleucine → valine substitution at codon 105 (Ile^105^ → Val^105^) in exon 5 and in second, a C→T transition at nucleotide 341 resulting in replacement of alanine → valine at the amino acid position114 (Ala^114^ → Val^114^) in exon 6. Hence, the human *GSTP1* locus comprises of four different alleles: *GSTP1*\*A (wild type Ile ^105^ → Ala^114^), *GSTP1*\*B (Val^105^ → Ala^114^), *GSTP1*\*C (Val ^105^ → Val ^114^) and *GSTP1*\*D (Ile^105^ → Val ^114^) ([@bb0050], [@bb0120], [@bb0150], [@bb0340]). GSTP1 plays a central role in the inactivation of toxic and carcinogenenic electrophiles ([@bb0135]). GST enzyme activity is significantly lower among individuals with 105Val allele due to polymorphism at nucleotide 313 in the *GSTP1* gene. GST genotypes conferring lower enzyme activity may be of advantage for individuals undergoing chemotherapeutic treatment for neoplastic disease because reduced detoxification potentially enhances effectiveness of cytotoxic drugs. Over the past decade, there has been considerable interest in the biological and clinical consequences of the reported GST polymorphisms. Considering the wide variation in the frequency of *GSTP1* alleles in different ethnic populations, we evaluated the distribution of GSTP1 alleles in Delhi population and compared it with the frequency reported in different states of India and other populations worldwide.

Materials and methods {#s0010}
=====================

Selection of controls {#s0025}
---------------------

Peripheral blood from 500 normal controls was collected in vials containing EDTA after receiving their informed consent. The controls selected for the study were either normal volunteers from the Institute, or normal healthy individuals visiting with the patients in various hospitals of Delhi. Information on age, sex, smoking and alcohol habits was obtained. The ethical clearance was obtained from our Institute\'s ethical committee.

PCR methodology {#s0030}
---------------

An ARMS (amplification refractory mutation system) assay, described by ([@bb0130]) was performed to identify four alleles of *GSTP1*, using two different sets of primers amplifying exon 5 and exon 6. It included a forward Primer upstream of the codon 105 substitution (5′-ACC CCA GGG CTC TAT GGG AA-3′) and two reverse primers; primer 'A' (5′-TCA CAT AGT CAT CCT TGC CGG-3′) (Ala ^114^ specific) and primer 'B' (5′-TCA CAT AGT CAT CCT TGC CGA-3) (Val ^114^ specific). Two PCRs were performed for each DNA sample. PCRs were performed in 50 μl reaction volume containing 50--100 ng of genomic DNA, 50 mM KCl, 2.5 mM MgCl~2~, 200 mM Tris (pH 8.4), 200 μM of dNTP each, 1.5 units of Ampli Taq DNA polymerase (Bangalore Genei), forward primer and reverse primers A or B (0.3 μM each). PCR was performed with initial denaturation at 94 °C for 5 min, followed by 35 cycles of denaturation at 94 °C for 1 min, annealing at 62 °C for 1 min, elongation at 72 °C for 2 min, and a final extension at 72 °C for 7 min. A 998 bp fragment was amplified ([Fig. 1](#f0005){ref-type="fig"}a).

PCR products were digested with BsmA1 restriction enzyme and resolved in 3.5 % agarose gel. Digested PCR products gave fragments of 73, 260, 322 and 343 bp with Ile ^105^ (*GSTP1*\*A or *GSTP1*\*D) and fragments of 73, 93, 250, 260, and 322 bp with Val ^105^ (*GSTP1*\*B or *GSTP1*\*C) and six fragments of 73, 93, 250, 260, 322, and 343 bp in heterozygote individuals (Ile ^105^/val^105^). The initial ARMS PCR was used to identify Ala^114^ or Val ^114^ genotypes. Therefore, amplification in individuals with Ala ^114^/Ala ^114^ was observed with reverse primer A, and with reverse primer B in individuals having Val ^114^/Val ^114^, and amplification in heterozygote for Ala ^114^/Val ^114^ was observed with both primers A and B. Therefore genotypes in various combinations (AA, AB, AC, BB, AD, BC, BD, CC, CD, and DD) were identified that resulted from A, B, C, and D alleles ([Fig. 1](#f0005){ref-type="fig"}b). Most of the studies have reported frequencies of Val and Ile alleles. The frequency of Ile105 and Val105 allele was calculated in the present study for the purpose of comparison with published data where all the four alleles were not analysed.

Statistical analysis {#s0035}
--------------------

The data were tabulated and analysed. The mean ± S.D. were computed for quantitative data. The distribution of the allele and genotype frequencies of *GSTP1* was determined by direct counting. Observed frequencies of genotypes in Delhi population were compared with other Indian as well as global populations using Chi square or Fisher\'s exact test when expected frequencies were small. Hardy--Weinberg equilibrium was calculated in this population and compared with other global populations. *P* value \< 0.05 was considered significant.

Results {#s0015}
=======

A total of 500 healthy individuals, 274 (54.8%) males: 226 (45.2% females participated in this study. The participants had a median age of 32 years, ranging from 18 to 57 years. The mean age of males and females was 33.1 ± 6.7and 32.6 ± 6.8 respectively and the age distribution was not different between both the sexes (*p* = 0.41). Of 500 individuals, 97 (19.4%) were smokers, 126 (26.5%) were alcoholics and 43(8.6%) were betel nut/tobacco chewers. Among the smokers, 85 (87.6%) were males and 12 (12.4%) were females.

[Table 1](#t0005){ref-type="table"} represents genotype and allele frequencies of *GSTP1* gene polymorphisms in Delhi population. All individuals were analyzed for *GSTP1* polymorphisms and most of them were having *GSTP1*AA (44.6%), *GSTP1* AB (33.8%) and *GSTP1* AC (8.2%) genotypes ([Table 1](#t0005){ref-type="table"}). The number of individuals with other genotypes was very less. Frequencies of four alleles of *GSTP1* namely *GSTP1*\*A, *GSTP1*\*B, *GSTP1*\*C and *GSTP1*\*D were 0.663, 0.248, 0.069 and 0.020 respectively ([Table 1](#t0005){ref-type="table"}). No significant difference in the frequencies of the *GSTP1* gene between males and females, smokers and non-smokers, alcoholics and non- alcoholics, tobacco chewers and non-chewers (*p* \> 0.05) was observed (data not shown).The frequency distribution of *GSTP1* alleles in Indian and global populations is tabulated in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}. There are only few studies where the frequency of *GSTP1*\*A, *GSTP1*\*B, *GSTP1*\*C and *GSTP1*\*D was calculated ([Table 2](#t0010){ref-type="table"}). In all these studies the differences in frequencies were not significant except in one study from Egypt, where the frequencies were reversed from that of our observation and the differences were highly significant (*p* \< 0.001). In Egyptians, both *GSTP1*\*C and *GSTP1*\*D alleles were not observed. *GSTP1*\*D was absent in two Italian studies and rare in other studies also ([Table 2](#t0010){ref-type="table"}).

In India the frequency of *GSTP1* Ile105/Ile105 allele was almost similar throughout India (*p* = 0.05) with a few exceptions ([@bb0045], [@bb0055], [@bb0095], [@bb0175], [@bb0250], [@bb0325], [@bb0330]), where the frequency was high. In one of the studies from Jammu & Kashmir ([@bb0250]) the frequency of *GSTP1* Ile105/Ile105 allele was so high as compared with the present study, that after including this single study the differences became significant (*p* \< 0.001) ([Table 3](#t0015){ref-type="table"}). The frequencies of *GSTP1* genotypes did not achieve Hardy--Weinberg equilibrium in the clubbed data of North Indians (*p* \< 0.001), South Indians (*p* \< 0.002) and Central Indians (*p* \< 0.01) ([Table 3](#t0015){ref-type="table"}).

We have calculated and compared the frequency of *GSTP1* alleles in four main world populations namely Africans, Europeans, Asians and Indians, with the present study ([Table 4](#t0020){ref-type="table"}). The gene frequency was obtained by clubbing the individual data from various populations. The mean gene frequency of Ile/Val allele was (0.657/0.343; *N* = 1606) in Africans, (0.686/0.314; *N* = 4655) in Europeans, (0.779/0.221; *N* = 3486) in Asians and (0.719/0.281; *N* = 3035) in Indians. Genotype frequencies of *GSTP1* Ile105Val polymorphism followed Hardy--Weinberg equilibrium in Europeans (*p* = 0.62), and Asians (*p* = 0.77) but not in Africans (*p* = 0.004) and Indians (*p* \< 0.001). The frequency of Ile105 and Val105 allele was observed to be 0.683 and 0.317 respectively in the present study and the population was in Hardy--Weinberg equilibrium. Highly significant (*p* \< 0.0001, df = 1, χ^2^ = 625.87) linkage disequilibrium was observed between Ile105 and Ala114 and between Val105 and Val114.

Discussion {#s0020}
==========

GSTs are involved in the biotransformation of exogenous substances, including mutagens, carcinogens, and other poisonous chemicals, and play a crucial role in the detoxification process, thereby protecting cells from these compounds ([@bb0310]). Epidemiological studies have suggested that individuals differing in the expression of allelic variants of *GSTP1* gene differ in susceptibility to various chemical carcinogens ([@bb0240]). In the present study we have examined the *GSTP1* Ile/Val polymorphism by ARMS assay to know the base data of *GSTP1*\*A, *GSTP1*\*B, *GSTP1*\*C and *GSTP1*\*D alleles in normal Delhi population. The information on frequencies of these four alleles was available in a few studies ([Table 2](#t0010){ref-type="table"}). They have also observed almost similar results and the differences in frequencies were not statistically significant when compared with the present study ([@bb0035], [@bb0040], [@bb0130]). However in one study from Egypt, statistically significant differences emerged. The reason for this variation is not known, may be the number of individuals was very less in that study ([@bb0005]).

The frequency distribution of GSTP1 alleles observed in the present study is almost similar throughout India except for Jammu & Kashmir, Lucknow, Central India and South India, thus suggesting a distinct difference among the Indian population. The reason for this diversity in the Indian population is believed to be because of different socio-cultural traditions, lifestyles and exposures.

Distinct ethnic differences also exist in the frequency of *GSTP1* Ile/Val polymorphism. The range of Ile allele frequency was 0.47--0.86 in Africans, 0.63--0.76 in Europeans, 0.67--0.92 in Asians and 0.59--0.84 in Indians (from data mentioned in [Table 4](#t0020){ref-type="table"}). The frequency distribution of mutant allele *Val105/Val105* was most frequent among South African Xhosas (0.53) and African American (0.51) and least frequent among Tanzanians (0.14) ([@bb0010], [@bb0090], [@bb0225]). The range of *Val105/Val105* allele was 0.14--0.53 in Africans, 0.23--0.37 in Caucasians, 0.08--0.33 in Asians and 0.16--0.41 in Indians (from data mentioned in [Table 4](#t0020){ref-type="table"}). *GSTP1 105Val* is less frequent in Asians as compared to Caucasians. A complete absence of the mutant homozygous *Val105/Val105* genotype was also reported in one of the studies from Japan ([@bb0170]). Observation from the present study of the genotype distribution of *GSTP1* Ile/Ile and Ile/Val reveals that it varies significantly from Asians (*p* \< 0.0001) but not from Africans, Europeans and Indians. Similar results were also observed in other studies ([@bb0230], [@bb0245], [@bb0315]).

The *GSTP1* Val/Val genotype is uncommon and exists in 5% of Caucasians ([@bb0110]). This form of the *GSTP1* enzyme has been reported to be 2--3 times less stable than the Ile105 form ([@bb0145]) and possibly associated with a higher level of DNA adducts ([@bb0265]). Individuals with *GSTP1* Val/Val genotype had significantly better survival in hepatocellular carcinoma patients ([@bb0065]), but this genotype is associated with worse outcome in basal cell carcinoma ([@bb0255]) and breast cancer ([@bb0355]). In a meta analysis it has been reported that individuals with *GSTP1* Ile105/Val 105 genotype increase susceptibility to breast cancer in Asian population ([@bb0205]), while a good response and light toxicity were also observed in breast cancer patients carrying *GSTP1* Ile105/Val 105 or Ile 105/Ile105 genotype ([@bb0355]). Individuals with homozygous genotypes of *GSTP1* Ile/Ile were reported to have the lowest risk of prostate cancer ([@bb0180]), and this genotype is found to be protective in rheumatoid arthritis ([@bb0220]) and basal cell carcinoma ([@bb0255]). An over expression of GSTP1 enzyme in individuals with Ile/Ile genotype causes resistance to drugs like cisplatin in oral and maxillofacial carcinoma ([@bb0320], [@bb0350]). Thus GST polymorphism studies will provide a clue to the identification of responders to cancer therapy with certain chemotherapeutic drugs.

GSTP1 associated risk is probably disease-dependent, and may reflect differences in relevant substrates. Individuals with different combinations of *GST* alleles would also help in studying the effect of various carcinogens in different populations having various exposures and giving personalised treatment in case of cancer. Understanding the contribution of *GST* gene polymorphisms and their interactions with other relevant factors may improve screening diagnostic assays for various cancers. Thus, our results signify the impact of ethnicity and provide a basis for future epidemiological and clinical studies.

Appendix A. Supplementary data {#s0040}
==============================

The following is the supplementary data related to this article.Table 5Allele and genotype frequencies of GSTP1 worldwide.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Supplementary data to this article can be found online at [http://dx.doi.org/10.1016/j.mgene.2013.12.003](10.1016/j.mgene.2013.12.003){#ir0005}.

![Representative photograph of *GSTP1* gene PCR showing 998 bp band of *GSTP1* and digested PCR product with BsmA1 restriction enzyme and resolved in 3.5% agarose gel using 100 bp ladder marker (M). (a) Samples 1 and 2 showing Ala 114 specific PCR while sample 3 is positive for both Ala 114 and Val114. (b) Digested PCR product showing AB and BC genotype of *GSTP1* gene.](gr1){#f0005}

###### 

*GSTP1* genotype and allele frequency in Delhi population.

  Genotype                         AA        AB       BB       AC       AD       BC       BD       CC       CD       DD
  -------------------------------- --------- -------- -------- -------- -------- -------- -------- -------- -------- ----
  No. of individuals (*N* = 500)   223       169      30       41       7        17       2        2        7        2
  (44.6%)                          (33.8%)   (6.0%)   (8.2%)   (1.4%)   (3.4%)   (0.4%)   (0.4%)   (1.4%)   (0.4%)   
                                                                                                                     

  Total number of alleles corresponding to above genotypes   Total alleles   Allele frequency                                            
  ---------------------------------------------------------- --------------- ------------------ ---- ---- --- ---- --- --- --- --- ----- -------
  *GSTP1*\*A alleles                                         446             169                     41   7                        663   0.663
  *GSTP1*\*B alleles                                                         169                60            17   2               248   0.248
  *GSTP1*\*C alleles                                                                                 41       17       4   7       69    0.069
  *GSTP1*\*D alleles                                                                                      7        2       7   4   20    0.020

###### 

Distribution of *GSTP1* genotypes and allele frequency by ARMS assay in various populations.

  Population     No. of individuals   *GSTP1*[⁎](#tf0005){ref-type="table-fn"}A   *GSTP1*[⁎](#tf0005){ref-type="table-fn"}B   *GSTP1*[⁎](#tf0005){ref-type="table-fn"}C   *GSTP1*[⁎](#tf0005){ref-type="table-fn"}D   *P* value                                       Reference
  -------------- -------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- ----------------------------------------------- ---------------
  European       58                   33                                          17                                          7                                           1                                           P = 0.41                                        ([@bb0130])
  (56.9; 0.57)   (29.3; 0.30)         (12.1; 0.12)                                (1.7; 0.01)                                                                                                                                                                         
  Italian        250                  177                                         60                                          13                                          0                                           *P* = 0.09                                      ([@bb0035])
  (70.8; 0.71)   (24.0; 0.24)         (5.2; 0.05)                                 0                                                                                                                                                                                   
  Italian        228                  164                                         52                                          12                                          0                                           *P* = 0.1                                       ([@bb0040])
  (71.9; 0.72)   (22.8; 0.23)         (5.26; 0.05)                                0                                                                                                                                                                                   
  Egyptian       40                   10                                          30                                          0                                           0                                           *P* \< 0.001[⁎](#tf0005){ref-type="table-fn"}   ([@bb0005])
  (25.0; 0.25)   (75.0; 0.75)         0                                           0                                                                                                                                                                                   
  Delhi          500                  331                                         124                                         35                                          10                                          Reference                                       Present study
  (66.2; 0.66)   (24.8; 0.25)         (7.0; 0.07)                                 (2.0; 0.02)                                                                                                                                                                         

Significant.

###### 

Genotype and allele frequencies of *GSTP1* in various Indian populations.

  Populations       Total number   Genotype   Allele   *P* value   References                                                          
  ----------------- -------------- ---------- -------- ----------- ------------ ------- ---------------------------------------------- --------------------------------------------------------------------
  North Indians     1179           596        531      52          0.731        0.269   *P* = 0.05                                     ([@bb0045], [@bb0175], [@bb0230], [@bb0250], [@bb0290], [@bb0300])
  (50.6%)           (45.0%)        (4.40%)                                                                                             
  South Indians     1448           720        635      93          0.717        0.283   *P* = 0.11                                     ([@bb0095], [@bb0190], [@bb0270], [@bb0290], [@bb0325], [@bb0330])
  (49.72%)          (43.86%)       (6.42%)                                                                                             
  Central Indians   40             18         12       10          0.60         0.40    *P* = 0.004[⁎](#tf0010){ref-type="table-fn"}   ([@bb0055])
  (44.0%)           (30.0%)        (26.0%)                                                                                             
  Present study     500            225        233      42          0.683        0.317   Reference                                      Present study
  (45.0%)           (46.60%)       (8.40%)                                                                                             

Significant, except the study done by [@bb0250].

###### 

Genotype and allele frequencies of *GSTP1* in Worldwide populations.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Population      Total no.   Genotype   Allele frequency   *P* value   References                             
  --------------- ----------- ---------- ------------------ ----------- ------------ ------- ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Africans        1606        725\       660\               221\        0.657        0.343   *P* = 0.33        ([@bb0010], [@bb0060], [@bb0090], [@bb0215], [@bb0225], [@bb0260], [@bb0340])
                              (45.14%)   (41.09%)           (13.77%)                                           

  Europeans       4655        2196\      1992\              467\        0.686        0.314   *P* = 0.90        ([@bb0015], [@bb0020], [@bb0100], [@bb0115], [@bb0120], [@bb0140], [@bb0180], [@bb0200], [@bb0225], [@bb0235], [@bb0280], [@bb0285], [@bb0290], [@bb0305], [@bb0335], [@bb0340], [@bb0345])
                              (47.18%)   (42.79%)           (10.03%)                                           

  Asians          3486        2119\      1194\              173\        0.779        0.221   *P* \< 0.0001\*   ([@bb0025], [@bb0030], [@bb0065], [@bb0070], [@bb0075], [@bb0160], [@bb0165], [@bb0170], [@bb0185], [@bb0195], [@bb0290], [@bb0340])
                              (60.79%)   (34.25%)           (4.96%)                                            

  Indians         3035        1518\      1329\              188\        0.719        0.281   *P* = 0.10        ([@bb0045], [@bb0055], [@bb0095], [@bb0175], [@bb0230], [@bb0250], [@bb0270], [@bb0290], [@bb0295], [@bb0300], [@bb0325], [@bb0330])
                              (50.01%)   (44.12%)           (5.87%)                                            

  Present study   500         225\       233\               42\         0.683        0.317   Reference         
                              (45.0%)    (46.6%)            (8.4%)                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
